SON-1410

N/A

Report date: 2023/12/15 08:45:53

Base Information

Drug NameSON-1410
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin 18 stimulantsInterleukin-12 stimulants
TargetsInterleukin 18Interleukin-12
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSonnet Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A